Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open-Label, Randomized, 3-Arm, Phase 3B Clinical Study to Investigate the Safety and Immunogenicity of a Concomitant Administration of Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate (MenC-TT) Vaccine and 7-Valent Pneumococcal CRM197-Conjugate Vaccine (PCV7) in Toddlers Previously Immunized During Infancy With PCV7

Next Previous
X
Search
Trial Profile

Open-Label, Randomized, 3-Arm, Phase 3B Clinical Study to Investigate the Safety and Immunogenicity of a Concomitant Administration of Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate (MenC-TT) Vaccine and 7-Valent Pneumococcal CRM197-Conjugate Vaccine (PCV7) in Toddlers Previously Immunized During Infancy With PCV7

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 29 May 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Meningococcal vaccine group C conjugate (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
  • Indications Bacterial meningitis; Pneumococcal infections
  • Focus Pharmacodynamics
  • Sponsors Baxter Healthcare Corporation

    • Most Recent Events

    • 09 Feb 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2007-004276-39).
    • 06 Jan 2010 Actual end date (December 2009) added as reported by ClinicalTrials.gov.
    • 06 Jan 2010 Actual patient number (330) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top